The pharmacological management of erectile dysfunction

South African Family Practice

 
 
Field Value
 
Title The pharmacological management of erectile dysfunction
 
Creator Marais, Andre
 
Subject — cardiovascular disease; erectile dysfunction; phosphodiesterase-5 inhibitors; prostaglandin; testosterone
Description The inability to attain or maintain a penile erection sufficient for sexual intercourse is a common problem experienced by a third of men over the age of 40 years. Erectile dysfunction (ED) is a debilitating disease which can have profound psychological effects on personal relationships and the social well-being of the affected individual. The diagnosis and evaluation of sexual dysfunction has been well described, and several validated algorithms are available to quantify the classification and severity. The International Index of Erectile Function and the Sexual Health Inventory for Men questionnaires are commonly used in the initial assessment of ED. Several risk factors have been linked to the pathophysiology of ED. Endothelial damage has been the focus of many recent studies. An evaluation of cardiovascular status, in addition to the administration of questionnaires to men with ED, might reduce mortality and improve sexual quality of life.
 
Publisher AOSIS
 
Contributor
Date 2015-07-01
 
Type info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion Peer-reviewed Article —
Format application/pdf
Identifier 10.4102/safp.v57i4.4298
 
Source South African Family Practice; Vol 57, No 4 (2015): July/August; 4 2078-6204 2078-6190
 
Language eng
 
Relation
The following web links (URLs) may trigger a file download or direct you to an alternative webpage to gain access to a publication file format of the published article:

https://safpj.co.za/index.php/safpj/article/view/4298/5166
 
Coverage — — —
ADVERTISEMENT